Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.

Satoshi KobayashiTaito FukushimaMakoto UenoMakoto ChumaKazushi NumataKota TsuruyaYoshitaka AraseShunji HiroseTatehiro KagawaNobuhiro HattoriTsunamasa WatanabeKotaro MatsunagaHaruki UojimaHisashi HidakaChika KusanoManabu MorimotoShin Maeda

Published in: Liver international : official journal of the International Association for the Study of the Liver (2024)

BCLCp-B1 stage was identified as a better prognostic factor for PPS following ATZ + BEV treatment compared with BCLCp-C1 and BCLCp-C2 stages. This may help in making decisions regarding subsequent treatment after ATZ + BEV.

Keyphrases

prognostic factors
replacement therapy
smoking cessation